Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine

Introduction. Human polyomavirus BK (BKV) is worldwide distributed, with a seroprevalence rate of 70–90% in the adults. Following primary infection, BK remains latent in the renourinary tract as the epidemiologically most relevant latency site, and in B cell, brain, spleen and probably other tissues...

Full description

Bibliographic Details
Main Authors: Sara Astegiano, Maria Elena Terlizzi, Samantha Mantovani, Maria Messina, Francesca Sidoti, Giuseppe P. Segoloni, Rossana Cavallo, Cristina Costa, Massimiliano Bergallo
Format: Article
Language:English
Published: PAGEPress Publications 2010-06-01
Series:Microbiologia Medica
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/mm/article/view/2465
_version_ 1811329377494892544
author Sara Astegiano
Maria Elena Terlizzi
Samantha Mantovani
Maria Messina
Francesca Sidoti
Giuseppe P. Segoloni
Rossana Cavallo
Cristina Costa
Massimiliano Bergallo
author_facet Sara Astegiano
Maria Elena Terlizzi
Samantha Mantovani
Maria Messina
Francesca Sidoti
Giuseppe P. Segoloni
Rossana Cavallo
Cristina Costa
Massimiliano Bergallo
author_sort Sara Astegiano
collection DOAJ
description Introduction. Human polyomavirus BK (BKV) is worldwide distributed, with a seroprevalence rate of 70–90% in the adults. Following primary infection, BK remains latent in the renourinary tract as the epidemiologically most relevant latency site, and in B cell, brain, spleen and probably other tissues. Reactivation may occur in both immunocompetent subjects and immunocompromised patients. In renal transplantation, in the context of intense immunosuppression, viral replication may determine BKV-associated nephropathy (BKVAN) with interstitial nephritis and/or ureteral stenosis in 1–10% of the patients and leading to graft failure and return to haemodialysis in 30 to 80% of the cases (5). Screening of BKV replication represents the basic strategy to predict early the onset of BKVAN and may allow for earlier intervention with reduced allograft loss (3, 4). Nowadays, replication of BKV is monitored by quantification of BKV-DNA in serum and urine (2). The aim of this study was to evaluated the role of BKV VP1 mRNA in urine as a marker of viral replication in renal transplant recipients.
first_indexed 2024-04-13T15:42:49Z
format Article
id doaj.art-1e21d3afdc8c4747a8d8a0169a700c16
institution Directory Open Access Journal
issn 2280-6423
language English
last_indexed 2024-04-13T15:42:49Z
publishDate 2010-06-01
publisher PAGEPress Publications
record_format Article
series Microbiologia Medica
spelling doaj.art-1e21d3afdc8c4747a8d8a0169a700c162022-12-22T02:41:04ZengPAGEPress PublicationsMicrobiologia Medica2280-64232010-06-0125210.4081/mm.2010.24651719Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urineSara AstegianoMaria Elena TerlizziSamantha MantovaniMaria MessinaFrancesca SidotiGiuseppe P. SegoloniRossana CavalloCristina CostaMassimiliano BergalloIntroduction. Human polyomavirus BK (BKV) is worldwide distributed, with a seroprevalence rate of 70–90% in the adults. Following primary infection, BK remains latent in the renourinary tract as the epidemiologically most relevant latency site, and in B cell, brain, spleen and probably other tissues. Reactivation may occur in both immunocompetent subjects and immunocompromised patients. In renal transplantation, in the context of intense immunosuppression, viral replication may determine BKV-associated nephropathy (BKVAN) with interstitial nephritis and/or ureteral stenosis in 1–10% of the patients and leading to graft failure and return to haemodialysis in 30 to 80% of the cases (5). Screening of BKV replication represents the basic strategy to predict early the onset of BKVAN and may allow for earlier intervention with reduced allograft loss (3, 4). Nowadays, replication of BKV is monitored by quantification of BKV-DNA in serum and urine (2). The aim of this study was to evaluated the role of BKV VP1 mRNA in urine as a marker of viral replication in renal transplant recipients.http://www.pagepressjournals.org/index.php/mm/article/view/2465BK virus, kidney transplantation, PCR
spellingShingle Sara Astegiano
Maria Elena Terlizzi
Samantha Mantovani
Maria Messina
Francesca Sidoti
Giuseppe P. Segoloni
Rossana Cavallo
Cristina Costa
Massimiliano Bergallo
Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
Microbiologia Medica
BK virus, kidney transplantation, PCR
title Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
title_full Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
title_fullStr Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
title_full_unstemmed Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
title_short Polyomavirus BK replication in renal transplant recipients: combined monitoring of viremia and VP1 mRNA in urine
title_sort polyomavirus bk replication in renal transplant recipients combined monitoring of viremia and vp1 mrna in urine
topic BK virus, kidney transplantation, PCR
url http://www.pagepressjournals.org/index.php/mm/article/view/2465
work_keys_str_mv AT saraastegiano polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT mariaelenaterlizzi polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT samanthamantovani polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT mariamessina polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT francescasidoti polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT giuseppepsegoloni polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT rossanacavallo polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT cristinacosta polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine
AT massimilianobergallo polyomavirusbkreplicationinrenaltransplantrecipientscombinedmonitoringofviremiaandvp1mrnainurine